Loading…
Attending this event?
Tuesday, June 18 • 3:15pm - 4:15pm
#276: The Promise of Disease Progression Modeling to Bring Treatments to Patients Sooner

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-608-L04-P; CME 1.00; RN 1.00

The impact of disease progression modeling (DPM) on medical product development has yet to be fully realized. This forum will describe DPM and its current applications in clinical trials and highlight the value of DPM to advance decision making and clinical development efficiency.

Learning Objectives

Describe disease progression modeling (DPM) and its current applications in clinical trials; Define the value of DPM to enhance decision making throughout the medical product development lifecycle; Discuss multi-stakeholder effort to advance clinical trial and medical product development efficiency through the increased recognition, value, and consistent use of DPM.

Chair

Summer Starling, DrPH, MPH

Speaker

Panelist
Herbert Pang, PhD, MBA

Panelist
Karthik Venkatakrishnan, PhD

Panelist
Jenny Chien, PhD


Speakers
avatar for Summer Starling

Summer Starling

Senior Project Manager, Clinical Trials Transformation Initiative (CTTI), United States
avatar for Jenny Chien

Jenny Chien

Associate Vice President, Global PK/PD and Pharmacometrics, Eli Lilly and Company, United States
Dr. Chien is an associate VP and a scientific lead in the Global PK/PD and Pharmacometrics Department at Eli Lilly and Company. She received her Ph.D. degree in Pharmaceutical Sciences from the University of Washington, Seattle in 1997. Dr. Chien is recognized for her expertise in... Read More →
avatar for Herbert Pang

Herbert Pang

Expert Statistical Scientist, Genentech, A Member of the Roche Group, United States
Herbert (Herb) Pang is an Expert Statistical Scientist at Genentech/Roche. His research interests include real-world evidence for drug development, machine learning, biomarker discovery, -omics data, and the design and analysis of clinical trials. Herb obtained his PhD in Biostatistics... Read More →
avatar for Karthik Venkatakrishnan

Karthik Venkatakrishnan

Vice President, Global Head of Quantitative Pharmacology, EMD Serono, United States
Karthik Venkatakrishnan is Vice President and Global Head of Quantitative Pharmacology at EMD Serono, Inc., Billerica, MA, with accountability for leadership of Clinical Pharmacology, Translational M&S, and Pharmacometrics. Previously, he held roles in Clinical Pharmacology at Pfizer... Read More →

Tuesday June 18, 2024 3:15pm - 4:15pm PDT
Room 14AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  11: Statistics-Data Science, Forum
  • Format Forum
  • Level Basic
  • Level Basic
  • Credit Type ACPE, CME, RN
  • Tags Forum